124 related articles for article (PubMed ID: 2407375)
1. Myocardial reperfusion injury. Histopathological effects of perfluorochemical.
Virmani R; Forman MB; Kolodgie FD
Circulation; 1990 Mar; 81(3 Suppl):IV57-68. PubMed ID: 2407375
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and therapy of myocardial reperfusion injury.
Forman MB; Virmani R; Puett DW
Circulation; 1990 Mar; 81(3 Suppl):IV69-78. PubMed ID: 2407376
[TBL] [Abstract][Full Text] [Related]
3. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Vinten-Johansen J
Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
[TBL] [Abstract][Full Text] [Related]
4. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
Forman MB; Ingram DA; Murray JJ
Am Heart J; 1992 Nov; 124(5):1347-57. PubMed ID: 1442506
[TBL] [Abstract][Full Text] [Related]
5. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%).
Kolodgie FD; Virmani R; Farb A
J Am Coll Cardiol; 1991 Jul; 18(1):215-23. PubMed ID: 2050924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
7. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
8. Free radicals and myocardial ischemia and reperfusion injury.
Simpson PJ; Lucchesi BR
J Lab Clin Med; 1987 Jul; 110(1):13-30. PubMed ID: 3298506
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tongxinluo on mini-swine vascular endothelial integrity and myocardial no-reflow in early reperfusion of acute myocardial infarction].
Zhang HT; Yang YJ; Wu YL; Cheng YT; Kang S; Zhao JL; Meng L; Tian Y; Zhang YW; Ye J; Meng XM
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1421-5. PubMed ID: 19671339
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
[TBL] [Abstract][Full Text] [Related]
11. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat.
Qi XL; Nguyen TL; Andries L; Sys SU; Rouleau JL
Can J Physiol Pharmacol; 1998 Jan; 76(1):35-45. PubMed ID: 9564547
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
Lefer AM
Ann Thorac Surg; 1995 Sep; 60(3):847-51. PubMed ID: 7677545
[TBL] [Abstract][Full Text] [Related]
15. Interstitial myocardial neutrophil accumulation between 3 and 72 h of reperfusion does not significantly affect infarct size in porcine hearts.
Bohle RM; Klein HH; Pich S; Lindert-Heimberg S; Gehrke D; Nebendahl K
Am J Cardiovasc Pathol; 1993; 4(4):336-42. PubMed ID: 8305196
[TBL] [Abstract][Full Text] [Related]
16. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postischemic reperfusion cardiac injury with a perfluorochemical solution.
Parrish MD; Olson RD; Mushlin PS; Artman M; Boucek RJ
J Cardiovasc Pharmacol; 1984; 6(1):159-64. PubMed ID: 6199599
[TBL] [Abstract][Full Text] [Related]
18. Role of adenosine as adjunctive therapy in acute myocardial infarction.
Forman MB; Stone GW; Jackson EK
Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725
[TBL] [Abstract][Full Text] [Related]
19. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
